 WARRINGTON, Pa., March 10, 2022 GLOBE NEWSWIRE -- Windtree Therapeutics, Inc. NasdaqCM: WINT, a biotechnology and medical device company focused on advancing multiple late-stage interventions for acute cardiovascular and pulmonary disorders, today announced that Craig Fraser, President and Chief Executive Officer, will present a corporate overview and be available for 1x1 meetings at the Oppenheimer 32nd Annual Healthcare Conference on Tuesday, March 15 at 1:20 p.m. Eastern Time. 